Ireland· IE-PA-PA1245/001/001
Lotemax 0.5% w/v eye drops, suspension
A loteprednol product containing loteprednol etabonate, registered in Ireland by Dr. Gerhard Mann, chem.-pharm. Fabrik GmbH. The same ATC class is registered in 6 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Loteprednol is registered in 6 of 19 countries.
Countries holding a registration under ATC S01BA14 (loteprednol), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 3 of them publish a price we can compare per daily dose
Loteprednol · ATC S01BA14
6 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Ireland
- Polandprice
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- Loteprednol etabonate
- Manufacturer
- Dr. Gerhard Mann, chem.-pharm. Fabrik GmbH
- Country
- Ireland (IE)
- ATC code
- S01BA14
- ATC class
- Loteprednol
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1245/001/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
57 interactions on record for loteprednol.
Graded by severity as the source publishes them — 16 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Loteprednol · interactions on record
57 records
- 16 moderate
- 41 info
Most severe, free to view
- MiconazoleA07AC01moderate
- KetoconazoleH02CA03moderate
- ErythromycinJ01FA01moderate
- ClarithromycinJ01FA09moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Loteprednol in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAlrexBausch & Lomb Incorporated
- CanadaALREXBAUSCH & LOMB INC
- PolandLotemax 0,5%Delfarma Sp. z o.o.
- CzechiaLOTEPREDNOL OLIKLAOlikla s.r.o., Kostelec nad Černými Lesy
- BelgiumLotemax 5 mg/mlBausch & Lomb Pharma
- GermanyLotemaxDr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Lotemax
- Cyprus · Lotemax
- Czechia · Loteprednol Olikla
- Germany · Lotemax
- Estonia · Lotemax
- United Kingdom (Northern Ireland) · Lotemax
- Greece · Lotemax
- Italy · Lotemax, Nolok
- Lithuania · Lotemax
- Poland · Lotemax
- Portugal · Xafex
- Slovenia · Lotemax
- Slovakia · Lotemax, Loteprednol Olikla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5af0dab3-b740-4566-a2b7-0252a8ed5e17 GET /v1/drugs/5af0dab3-b740-4566-a2b7-0252a8ed5e17?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Eye drops, suspension",
"routes": [
"Ocular use"
],
"source": "hpra",
"atc_all": [
"S01BA",
"S01BA14"
],
"strength": null,
"pa_number": "PA1245/001/001",
"substances": [
"Loteprednol etabonate"
],
"legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "10/11/2006",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about loteprednol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.